// company-profile

Protalix BioTherapeutics, Inc.

PLX
ExchangeNYSESectorBiological Products, (No Diagnostic Substances)Inc.DEFilings27Insiders11
// api This Protalix BioTherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for PLX in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Protalix BioTherapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$35.5M
QoQ change
+77.2%
Reporting period
2026-03-31
#1
MAK CAPITAL ONE LLC
CIK 1385702
$7.7M
3.5M shares
#2
BlackRock, Inc.
CIK 2012383
$5.3M
2.5M shares
#3
RENAISSANCE TECHNOLOGIES LLC
CIK 1037389
$2.7M
1.2M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Dec 19, 2025Bashan DrorPLX
Purchase
56,000$1.81$101K
Nov 18, 2025Bar-Shalev AmosPLX
Sale
168$1.87$0K
Sep 3, 2025Schwartz AharonPLX
Award
7,500
Sep 3, 2025Melincoff Gwen APLX
Award
7,500
Sep 3, 2025Schwartz AharonPLX
Award
15,000$0.00$0K

33 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.